Log in

Fate Therapeutics Earnings Date, Estimates & History (NASDAQ:FATE)

$18.91
-0.41 (-2.12 %)
(As of 12/11/2019 08:18 AM ET)
Today's Range
$18.33
Now: $18.91
$19.44
50-Day Range
$13.60
MA: $14.87
$19.32
52-Week Range
$11.00
Now: $18.91
$22.82
Volume2.04 million shs
Average Volume773,088 shs
Market Capitalization$1.43 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.86

Earnings

Fate Therapeutics (NASDAQ:FATE) Earnings Information

Fate Therapeutics last posted its earnings data on November 5th, 2019. The biopharmaceutical company reported ($0.40) earnings per share for the quarter, missing analysts' consensus estimates of ($0.38) by $0.02. The firm had revenue of $2.43 million for the quarter, compared to analyst estimates of $1.75 million. Its quarterly revenue was up 136.7% compared to the same quarter last year. Fate Therapeutics has generated ($1.19) earnings per share over the last year. Fate Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 3rd, 2020 based off prior year's report dates.

Fate Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Fate Therapeutics (NASDAQ:FATE) Earnings Estimates

2019 EPS Consensus Estimate: ($1.34)
2020 EPS Consensus Estimate: ($1.60)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20194($0.29)($0.19)($0.25)
Q2 20194($0.34)($0.27)($0.32)
Q3 20194($0.41)($0.35)($0.38)
Q4 20195($0.44)($0.35)($0.39)
Q1 20203($0.42)($0.35)($0.38)
Q2 20203($0.44)($0.33)($0.38)
Q3 20203($0.47)($0.38)($0.41)
Q4 20203($0.48)($0.38)($0.42)
Q1 20213($0.48)($0.38)($0.43)
Q2 20213($0.51)($0.39)($0.45)
Q3 20213($0.54)($0.31)($0.44)

Fate Therapeutics (NASDAQ FATE) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/3/2020
(Estimated)
       
11/5/2019Q3 2019($0.38)($0.40)($0.40)$1.75 million$2.43 millionTranscript
8/6/2019Q2 2019($0.32)($0.36)($0.36)$1.09 million$2.80 millionListen
5/7/20193/31/2019($0.23)($0.30)($0.30)$2.01 million$2.63 millionListen
3/5/2019Q4 2018($0.23)($0.25)($0.25)$3.51 million$1.66 millionTranscript
11/1/2018Q3($0.25)($0.31)($0.31)$1.24 million$1.03 millionListen
8/6/2018Q2 2018($0.32)($0.37)($0.37)$1.02 million$1.00 millionN/A
5/10/2018Q1 2018($0.22)($0.27)($0.27)$1.82 million$1.00 millionN/A
3/5/2018Q4 2017($0.24)($0.29)($0.29)$1.02 million$1.03 millionTranscript
11/1/2017Q3 2017($0.25)($0.26)($0.26)$0.95 million$1.03 millionN/A
8/14/2017Q2 2017($0.2360)($0.23)($0.23)$1.02 million$1.03 millionN/A
5/15/2017Q1 2017($0.21)($0.24)($0.24)$1.04 million$1.03 millionN/A
3/16/2017Q4 2016($0.2830)($0.21)($0.21)$1.06 million$1.03 millionN/A
11/7/2016Q316($0.29)($0.27)($0.27)$1.05 million$1.03 millionListen
8/8/2016Q216($0.32)($0.29)($0.29)$1.02 million$1.03 millionN/A
5/9/2016Q116($0.25)($0.29)($0.29)$0.84 million$1.32 millionN/A
3/3/2016Q415($0.27)($0.26)($0.26)$0.58 million$1.08 millionN/A
11/3/2015Q315($0.32)($0.24)($0.24)$0.46 million$1.03 millionN/A
8/5/2015Q215($0.39)($0.33)($0.33)$0.31 million$0.33 millionN/A
5/7/2015Q115($0.34)($0.38)($0.38)Listen
3/12/2015Q414($0.31)($0.30)($0.30)Listen
11/11/2014Q3 2014($0.29)($0.30)($0.28)N/A
8/12/2014Q214($0.36)($0.30)($0.30)Transcript
5/13/2014Q114($0.32)($0.34)($0.34)Listen
3/17/2014Q4 2013($0.29)($0.29)($0.29)N/A
11/13/2013Q3 2013($0.37)($4.81)($4.81)$0.21 millionListen
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 12/11/2019 by MarketBeat.com Staff

Featured Article: Management Fee

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel